Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

ketoconazole

×

Overview

What is EXTINA?

EXTINA Foam contains 2% ketoconazole USP, an antifungal agent, in a thermolabile hydroethanolic foam for topical application.

The chemical name for ketoconazole is piperazine, 1-acetyl-4-[4-[[2-(2,4-dichlorophenyl) -2-(1-imidazol-l-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-, - with the molecular formula CHClNO and a molecular weight of 531.43. The following is the chemical structure:

EXTINA Foam contains 20 mg ketoconazole per gram in a thermolabile hydroethanolic foam vehicle consisting of cetyl alcohol, citric acid, ethanol (denatured with -butyl alcohol and brucine sulfate) 58%, polysorbate 60, potassium citrate, propylene glycol, purified water, and stearyl alcohol pressurized with a hydrocarbon (propane/butane) propellant.



What does EXTINA look like?



What are the available doses of EXTINA?

EXTINA Foam contains 2% ketoconazole in a thermolabile hydroethanolic foam in 50 g and 100 g containers ().

What should I talk to my health care provider before I take EXTINA?

How should I use EXTINA?

EXTINA (ketoconazole) Foam, 2% is indicated for the topical treatment of seborrheic dermatitis in immunocompetent patients 12 years of age and older. Safety and efficacy of EXTINA Foam for treatment of fungal infections have not been established.

EXTINA Foam should be applied to the affected area(s) twice daily for four weeks.

Hold the container upright, and dispense EXTINA Foam into the cap of the can or other cool surface in an amount sufficient to cover the affected area(s). Dispensing directly onto hands is not recommended, as the foam will begin to melt immediately upon contact with warm skin. Pick up small amounts of EXTINA Foam with the fingertips, and gently massage into the affected area(s) until the foam disappears. For hair-bearing areas, part the hair, so that EXTINA Foam may be applied directly to the skin (rather than on the hair).

Avoid contact with the eyes and other mucous membranes. EXTINA Foam is not for ophthalmic, oral or intravaginal use.


What interacts with EXTINA?

Sorry No Records found


What are the warnings of EXTINA?

Sorry No Records found


What are the precautions of EXTINA?

Sorry No Records found


What are the side effects of EXTINA?

Sorry No records found


What should I look out for while using EXTINA?

None


What might happen if I take too much EXTINA?

Sorry No Records found


How should I store and handle EXTINA?

Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Manufactured and Distributed by: Carlsbad, CA 92008 Repackaged By :Aidarex Pharmaceuticals LLC,Corona, CA 92880Revised: 06/12CTI-12 Rev. C Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Manufactured and Distributed by: Carlsbad, CA 92008 Repackaged By :Aidarex Pharmaceuticals LLC,Corona, CA 92880Revised: 06/12CTI-12 Rev. C Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Manufactured and Distributed by: Carlsbad, CA 92008 Repackaged By :Aidarex Pharmaceuticals LLC,Corona, CA 92880Revised: 06/12CTI-12 Rev. C Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Manufactured and Distributed by: Carlsbad, CA 92008 Repackaged By :Aidarex Pharmaceuticals LLC,Corona, CA 92880Revised: 06/12CTI-12 Rev. C EXTINA Foam, 2% is supplied in 50 g (NDC 40076-051-50) and 100 g (NDC 40076-051-00) aluminum containers. Store at controlled room temperature 68° to 77°F (20° to 25°C). Do not store under refrigerated conditions. Do not store in direct sunlight. Contents are flammable. Contents under pressure. Do not puncture and/or incinerate container. Keep out of reach of children. EXTINA Foam, 2% is supplied in 50 g (NDC 40076-051-50) and 100 g (NDC 40076-051-00) aluminum containers. Store at controlled room temperature 68° to 77°F (20° to 25°C). Do not store under refrigerated conditions. Do not store in direct sunlight. Contents are flammable. Contents under pressure. Do not puncture and/or incinerate container. Keep out of reach of children. EXTINA Foam, 2% is supplied in 50 g (NDC 40076-051-50) and 100 g (NDC 40076-051-00) aluminum containers. Store at controlled room temperature 68° to 77°F (20° to 25°C). Do not store under refrigerated conditions. Do not store in direct sunlight. Contents are flammable. Contents under pressure. Do not puncture and/or incinerate container. Keep out of reach of children. EXTINA Foam, 2% is supplied in 50 g (NDC 40076-051-50) and 100 g (NDC 40076-051-00) aluminum containers. Store at controlled room temperature 68° to 77°F (20° to 25°C). Do not store under refrigerated conditions. Do not store in direct sunlight. Contents are flammable. Contents under pressure. Do not puncture and/or incinerate container. Keep out of reach of children. EXTINA Foam, 2% is supplied in 50 g (NDC 40076-051-50) and 100 g (NDC 40076-051-00) aluminum containers. Store at controlled room temperature 68° to 77°F (20° to 25°C). Do not store under refrigerated conditions. Do not store in direct sunlight. Contents are flammable. Contents under pressure. Do not puncture and/or incinerate container. Keep out of reach of children.


×

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

The mechanism of action of ketoconazole in the treatment of seborrheic dermatitis is not known.

Non-Clinical Toxicology
None

There is evidence that the anticonvulsant action of phenytoin is antagonized by folic acid. A patient whose epilepsy is completely controlled by phenytoin may require increased doses to prevent convulsions if folic acid is given.

Folate deficiency may result from increased loss of folate, as in renal dialysis and/or interference with metabolism (e.g., folic acid antagonists such as methotrexate); the administration of anticonvulsants, such as diphenylhydantoin, primidone, and barbiturates; alcohol consumption and, especially, alcoholic cirrhosis; and the administration of pyrimethamine and nitrofurantoin.

False low serum and red cell folate levels may occur if the patient has been taking antibiotics, such as tetracycline, which suppress the growth of .

EXTINA Foam may result in contact sensitization, including photoallergenicity.

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Review

Rate this treatment and share your opinion


Learn about User Reviews

Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

Effectiveness (required)

This medication has worked for me.




Ease of Use (required)

This medication has been easy for me to use.




Satisfaction (required)

Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
×

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
×

Tips

Tips

×

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).